Search for: "Roche Holding Ltd"
Results 1 - 20
of 83
Sort by Relevance
|
Sort by Date
11 Oct 2023, 1:23 am
Ltd. [read post]
29 Jun 2023, 12:29 am
The appellant requested that the decision of the opposition division not to admit document D18 into the proceedings be overturned.1.1 This request is subject to the Board's discretionary power to hold inadmissible facts, evidence and requests which could have been presented or were not admitted in the first instance proceedings (Article 12(4) RPBA 2007, which applies in view of Article 25(2) RPBA 2020). [read post]
25 Feb 2023, 6:50 pm
The critics and cheerleaders of Dr. [read post]
5 Sep 2022, 4:58 am
Care Renal Pharma Ltd. v. [read post]
12 Aug 2022, 6:48 pm
Hoffman-La Roche Ltd, 580 F.3d 1340, 1365–67 (Fed. [read post]
19 Mar 2021, 2:01 pm
Roche Holding Ltd., 292 F.3d 361, 374 n.7 (3rd Cir. 2002)). [read post]
17 Jan 2021, 6:15 pm
The Court in Crookes reinterpreted the notion of publication online, finding that a deliberate act can include the failure to remove defamatory content once actual or constructive knowledge exists, [59] A more nuanced approach to revising the publication rule, and one that can be applied effectively to new media, would be for the Court to hold that in Canadian law, a reference to defamatory content can satisfy the requirements of the first component of publication if it makes the… [read post]
24 Feb 2016, 10:04 am
Hoffmann-La Roche Ltd. v. [read post]
1 Feb 2016, 8:11 am
Hoffman-La Roche Ltd., 580 F.3d 1340 (Fed. [read post]
11 Feb 2015, 12:23 pm
Bayer’s predecessor, Hoffmann-La Roche, filed a US application for FLANAX in February 2004. [read post]
7 Nov 2014, 5:52 am
We’ve made no secret of our distaste for the so called “heeding presumption” – that juries may presume that any alternative “adequate” warning would have been heeded by the plaintiff (or, in prescription medical product cases, the prescriber). [read post]
30 Jul 2014, 12:01 am
Hoffman-La Roche Ltd. v. [read post]
21 Feb 2014, 8:53 am
Sun Pharmaceutical Industries Ltd., 909 F. [read post]
4 Nov 2013, 9:00 am
Polyphor Ltd., the Allschwil, Switzerland-based developer of the antibiotic, will receive 35 million francs up front, and is eligible for further payments of as much as 465 million francs if the product meets development, regulatory and commercial goals, Roche said in an e-mailed statement today.Roche also will pay royalties on sales, the Basel, Switzerland-based company said. [read post]
7 Oct 2013, 11:06 am
Hoffman-LA Roche Ltd., 580 F.3d 1340, 1362 (Fed. [read post]
23 Jul 2013, 8:43 am
Hoffmann - La Roche Inc., 541 F.3d 1115, 1122 (Fed. [read post]
2 Oct 2012, 1:08 pm
Jeffrey Alan Lowrance and First Capital Savings & Loan, Ltd. [read post]
27 Aug 2012, 11:01 am
Hoffman La-Roche Ltd., 580 F.3d 1340 (Fed. [read post]
27 Aug 2012, 9:31 am
Hoffmann-La Roche Ltd., 580 F.3d 1340 (Fed. [read post]
27 Aug 2012, 9:31 am
Hoffmann-La Roche Ltd., 580 F.3d 1340 (Fed. [read post]
